Achilles Therapeutics plc - stock earnings
ACHL Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -16.7 million USD | ? USD |
| 2023Q2 | -16.8 million USD | ? USD |
| 2023Q1 | -17.5 million USD | ? USD |
| 2022Q4 | -24.1 million USD | ? USD |
| 2022Q3 | -12.5 million USD | ? USD |
| 2022Q2 | -17.3 million USD | ? USD |
| 2022Q1 | -17.4 million USD | ? USD |
| 2021Q4 | -18.2 million USD | ? USD |
| 2021Q3 | -12.9 million USD | ? USD |
| 2021Q2 | -16.2 million USD | ? USD |
| 2021Q1 | -13.8 million USD | ? USD |
| 2020Q4 | -12.9 million USD | ? USD |
| 2020Q3 | -8.2 million USD | ? USD |
| 2020Q2 | -6.9 million USD | ? USD |
| 2020Q1 | -5.2 million USD | ? USD |
| 2019Q4 | -8.3 million USD | ? USD |
| 2019Q3 | -3.5 million USD | ? USD |
| 2019Q2 | -3.5 million USD | ? USD |
| 2019Q1 | -3.5 million USD | ? USD |
| 2018Q4 | -3.5 million USD | ? USD |
ACHL Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -75.1 million USD | ? USD |
| 2022 | -71.2 million USD | ? USD |
| 2021 | -61.1 million USD | ? USD |
| 2020 | -33.2 million USD | ? USD |
| 2019 | -14.0 million USD | ? USD |
| 2018 | -6.9 million USD | ? USD |
ACHL
Price: $0.78
52 week price:
Earnings Per Share: -1.74 USD
P/E Ratio: -0.50
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 354400
Market Capitalization: 35.3 million